1. Home
  2. LGO vs VTGN Comparison

LGO vs VTGN Comparison

Compare LGO & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGO
  • VTGN
  • Stock Information
  • Founded
  • LGO 1988
  • VTGN 1998
  • Country
  • LGO Canada
  • VTGN United States
  • Employees
  • LGO N/A
  • VTGN N/A
  • Industry
  • LGO
  • VTGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGO
  • VTGN Health Care
  • Exchange
  • LGO Nasdaq
  • VTGN Nasdaq
  • Market Cap
  • LGO 100.0M
  • VTGN 87.2M
  • IPO Year
  • LGO 2007
  • VTGN N/A
  • Fundamental
  • Price
  • LGO $1.50
  • VTGN $3.61
  • Analyst Decision
  • LGO Strong Buy
  • VTGN
  • Analyst Count
  • LGO 1
  • VTGN 0
  • Target Price
  • LGO $3.70
  • VTGN N/A
  • AVG Volume (30 Days)
  • LGO 132.7K
  • VTGN 625.3K
  • Earning Date
  • LGO 08-12-2025
  • VTGN 11-06-2025
  • Dividend Yield
  • LGO N/A
  • VTGN N/A
  • EPS Growth
  • LGO N/A
  • VTGN N/A
  • EPS
  • LGO N/A
  • VTGN N/A
  • Revenue
  • LGO $108,526,000.00
  • VTGN $646,000.00
  • Revenue This Year
  • LGO N/A
  • VTGN $46.91
  • Revenue Next Year
  • LGO $54.96
  • VTGN $504.34
  • P/E Ratio
  • LGO N/A
  • VTGN N/A
  • Revenue Growth
  • LGO N/A
  • VTGN N/A
  • 52 Week Low
  • LGO $1.12
  • VTGN $1.90
  • 52 Week High
  • LGO $2.84
  • VTGN $3.88
  • Technical
  • Relative Strength Index (RSI)
  • LGO 55.80
  • VTGN 64.74
  • Support Level
  • LGO $1.32
  • VTGN $3.45
  • Resistance Level
  • LGO $1.56
  • VTGN $3.88
  • Average True Range (ATR)
  • LGO 0.08
  • VTGN 0.20
  • MACD
  • LGO 0.00
  • VTGN 0.02
  • Stochastic Oscillator
  • LGO 75.00
  • VTGN 70.65

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: